USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Chr. Hansen HMO GmbH

USPTO PatentsView assignee record - 17 granted patents across 15 technology areas, recorded in grant years 2022–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture).

RSS updates for this company

The verdict

According to USPTO PatentsView, Chr. ranks #16,684 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 15 technology areas.

#16,684
of 49,997 US assignees by volume
Top 11%
by Innovation Score (52.0/100)
13.9
avg claims per patent

USPTO PatentsView assignee plate

Corpus R16684 · Foreign Corporation #16,684 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 17 grants
  • MID-PACK #16,684/49,997
  • PHOTO-FINISH Chengdu Vistar…
  • CPC-FOCUS C12P · 15 areas
  • INNOV-PAR 52.0/100
  • CLAIMS-RICH 13.9 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2022–2024 · 3y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Chengdu Vistar Optoelectronics Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Chr.’s 52.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Chr.

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Chr.'s Innovation Score is 52.0/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Chr.?

Each dot is one of Chr.’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Chr.’s own 13.9 claims/patent is ABOVE the 12.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Chr. vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 16.916.91717.1 0102030 Granted patents (volume) Avg claims / patent Chengdu Vistar Optoelectronics Co., Ltd. - 17, 16.29Chengdu Vistar Op…Chi Hua Fitness Co., Ltd. - 17, 5.71Chi Hua FitnessChina Pacificarbide, Inc. - 17, 1China Pacificarbi…Choice Spine, LLC - 17, 7.82Choice SpineChromaDex Inc. - 17, 20ChromadexCiambella Ltd. - 17, 18.71CiambellaClayton Corporation - 17, 12.29ClaytonCloudparc, Inc. - 17, 27.65CloudparcChr. Hansen HMO GmbH - 17, 13.88Chr Hansen HMO
Chr. vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Chr.'s grants concentrate

Chr. Hansen HMO GmbH is a focused PatentsView assignee: 15 CPC subclasses with 88.2% of grants classified under C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture). Peak complete grant year is 2024 (8 grants) versus a trough of 2 in 2022. By volume, Chr. sits between Chengdu Vistar Optoelectronics Co., Ltd. and Cloudparc, Inc..

Chr.'s three-year grant acceleration

Chr. Hansen HMO GmbH shows 17 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Chr's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Chr. holds 17 patents at rank #16,698, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Chr

By rank, the assignees closest to #16,698 in granted patent volume.

Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)

Other assignees with the most granted patents in Chr's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Chr, neither rank-band nor same-CPC leaders (those blocks stay above). In C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…), Chr ranks #128 of 1,268 assignees by patent count in that subclass.

Chr.'s Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

52 Top 11% higher than 89% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 202220232024 8
USPTO utility patent grants by year · 2022–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
Chr. Hansen HMO GmbH patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 2 11.8%
2023 7 41.2%
2024 8 47.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Chr. Hansen HMO GmbH's patent record in context - here's where to go next.

  • Chr. Hansen HMO GmbH's lead technology class is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture), 88.2% of its portfolio - see every assignee active in that class. Explore C12P
  • Ranked #16,684 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Chr. Hansen HMO GmbH against Chengdu Vistar Optoelectronics Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 52.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.